Merck

Merck continues to extend its footprint in the pharmaceuticals sector from its Rahway headquarters. The company's resilience, supported by 71k employees and an annual revenue near $60B, makes it a structural reference for investors and partners across North America.

The group's regional balance sheet allows it to invest counter-cyclically, an advantage few competitors can match in the current rate environment.

“Merck is, in its category, exactly the kind of compounding regional champion the next decade of capital allocation will reward.”

Analysts increasingly view the group as a regional bellwether — its quarterly trajectory tends to anticipate sector-wide moves.